Each actuation contains: Mometasone Furoate monohydrate equivalent to Mometasone Furoate 50 mcg, it is an anti-inflammatory corticosteroid.
It is indicated in the following conditions:
Treatment of Nasal Polyps: Mometasone furoate monohydrate Nasal Spray 50 mcg is indicated for the treatment of nasal polyps and associated symptoms including congestion and loss of smell in adult patients 18 years of age and older.
Treatment of symptoms of acute rhinosinusitis: Mometasone furoate monohydrate Nasal Spray 50 mcg is indicated for the treatment of symptoms associated with acute rhinosinusitis in patients 12 years of age and older wihtout signs and symptoms of severe bacterial infection.
Treatment of acute episodes of sinusitis as adjunctive treatment to antibiotic: Mometasone furoate monohydrate Nasal Spray 50 mcg is also indicated for use in adults and adolescents 12 years of age and older as adjunctive treatment to antibiotic for acute episodes of sinusitis.
Directions for use.
Administer Mometasone furoate monohydrate Nasal Spray 50 mcg by the intranasal route only. Prior to initial use of Mometasone furoate monohydrate Nasal Spray 50 mcg, the pump must be primed by actuating ten times or until a fine spray appears. The pump may be stored unused for up to 1 week without repriming. If unused for more than 1 week, reprime by actuating two times, or until a fine spray appears.
Treatment of Nasal Polyps: Adults 18 Years of Age and Older: The recommended dose for the treatment of nasal polyps is 2 sprays (50 mcg of mometasone furoate in each spray) in each nostril twice daily (total daily dose of 400 mcg). A dose of 2 sprays (50 mcg of mometasone furoate in each spray) in each nostril once daily (total daily dose of 200 mcg) is also effective in some patients.
Acute Rhinosinusitus: The usual recommended dose for acute rhinosinusitis is two actuations (50 micrograms/actuation) in each nostril twice daily (total daily dose of 400 micrograms). If symptoms worsen drug treatment, the patient should be advised to consult their physician.
Adjunctive treatment of acute episodes of sinusitis: Adults (including geriatric patients) and adolescents 12 years of age and older: The usual recommended dose is two sprays (50 micrograms/spray) in each nostril twice daily (total dose 400 micrograms).
If symptoms are inadequately controlled, the dose may be increased to four sprays (50 micrograms/spray) in each nostril twice daily (total dose 800 micrograms).
Precautions
Precautions
Mometasone furoate monohydrate Nasal Spray is contraindicated in patients with known hypersensitivity to mometasone furoate or any of its ingredients. Mometasone furoate monohydrate Nasal Spray should not be used in the presence of untreated localised infection involving the nasal mucosa.
Because of the inhibitory effect of corticosteroids on wound healing patients who have experienced recent nasal surgery or trauma should not use a nasal corticosteroid until healing has occurred.
